Genelux (GNLX) Accumulated Expenses (2022 - 2026)
Genelux's (GNLX) quarterly Accumulated Expenses came in at $861000.0 in Q1 2026, down 40.21% quarter-over-quarter from $1.4 million in Q4 2025.
Genelux (GNLX) Accumulated Expenses (2022 - 2026) Analysis & Trends
Genelux's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $861000.0 for Q1 2026.
- On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $861000.0 in Q1 2026; TTM through Mar 2026 was $861000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, down 78.1% from the prior year.
- Accumulated Expenses fell to $861000.0 in Q1 2026 per GNLX's latest filing, from $1.4 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $6.6 million in Q4 2024 and bottomed at $11000.0 in Q3 2023.
- The 5-year median for Accumulated Expenses is $861000.0 (2026), against an average of $1.5 million.
- Across the five-year window, Accumulated Expenses soared 6136.36% in 2024 and tumbled 78.1% in 2025, its largest moves.
- Year by year, Accumulated Expenses stood at $1.2 million in 2022, then jumped by 79.71% to $2.1 million in 2023, then jumped by 210.53% to $6.6 million in 2024, then tumbled by 78.1% to $1.4 million in 2025, then tumbled by 40.21% to $861000.0 in 2026.
- Per Business Quant, the three latest GNLX Accumulated Expenses figures stand at $861000.0 (Q1 2026), $1.4 million (Q4 2025), and $800000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 610,000.00 |
| Dec 31, 2024 | 6.57 Mn |
| Sep 30, 2024 | 686,000.00 |
| Jun 30, 2024 | 517,000.00 |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Sep 30, 2023 | 11,000.00 |
| Dec 31, 2022 | 1.18 Mn |